Most liver transplant recipients mount adequate COVID-19 antibody response

Loading

The majority of liver transplant recipients are able to produce a functional antibody response to COVID-19 infection, according to data published in Gut.

“Our findings suggest that the humoral response of [liver transplant (LT)] recipients is only slightly lower than expected compared with that of COVID-19 immunocompetent controls,” Chiara Becchetti, MD, of the department of visceral surgery and medicine at the University of Bern in Switzerland, and colleagues wrote. “Additionally, we showed that the majority of LT recipients is capable of mounting an adequate neutralizing activity against SARS-CoV-2 and that neutralizing ability was associated with the presence of antinucleocapsid antibodies.” Learn more here.

Loading

Cleveland Clinic’s Weston Hospital Performs First Living Donor Liver Transplant

Loading

“Cleveland Clinic’s Weston Hospital has performed its first living donor liver transplant, in which a daughter donated a portion of her liver to her mother who had been battling complicated liver disease for several years.  

The donor and recipient surgeries were performed in Weston by a team of surgeons from Cleveland Clinic Weston and Cleveland Clinic in Ohio, which has one of the nation’s largest living donor liver transplant programs.

On May 10, 2021, Cristiano Quintini, M.D., director of Liver Transplantation at Cleveland Clinic in Ohio, and Weston Hospital transplant surgeons Samer Ebaid, M.D., Ph.D., and Phoenix Vuong, M.D., removed 60 percent of the right lobe of 38 year-old Heidy Lima’s liver through an abdominal incision.”

Read more, here.

Loading